RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.310
+0.020 (1.55%)
At close: Oct 26, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: Oct 26, 2026, 7:30 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $59.12 million as of October 26, 2026. It is the 28,858th most valuable company in the world and the 4,491st biggest in the United States. Its market cap has increased by 36.72% in one year.
Market Cap
59.12M
Enterprise Value
50.03M
1-Year Change
36.72%
Global Rank
Country Rank
#4,491 United States
Category
ChartMarket Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $59.12M, a decrease of -13.87%. That is a compound annual growth rate of -2.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 59.12M | 92.01% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 60.64M |
| XBiotech | 58.84M |
| Gossamer Bio | 58.75M |
| OS Therapies | 57.76M |
| Heron Therapeutics | 57.49M |
| Caribou Biosciences | 57.12M |
| Clene | 55.15M |
| Gain Therapeutics | 54.99M |